Plus Therapeutics gets Nasdaq extension until May 11, 2026 to regain $1 bid price

PLUS THERAPEUTICS, INC.

Received 180-day extension to May 11, 2026 from Nasdaq to meet $1.00 minimum bid price rule.
No immediate effect on listing; stock continues trading on Nasdaq under PSTV.
If bid price closes at $1.00+ for 10 consecutive days, compliance confirmed and matter closed.
Company may implement reverse stock split if needed; no guarantee of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.